[1]
2024. Effectiveness of Ixekizumab in Elderly Patients for the Treatment of Moderate-to-Severe Psoriasis: Results From a Multicenter, Retrospective Real-Life Study in the Lazio Region. Dermatology Practical & Conceptual. 14, 3 (Jul. 2024), e2024166. DOI:https://doi.org/10.5826/dpc.1403a166.